FEMYNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
FEMASYS INC
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$1.63−0.02 (-1.21%)
Close on Oct 19, 2026
- Market cap
- $5.47M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$12.43 (−88.41%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.EarningsSplit
FEMASYS INC grew revenue 21.9% to $2.30M over the twelve months to Jun 30, 2026. Free cash flow was -$18.07M.
Revenue
$2.30M
+21.9% vs. a year earlier
Operating income
-$17.57M
TTM Q2 2026
Free cash flow
-$18.07M
TTM Q2 2026
EPS, diluted
-$4.58
TTM Q2 2026
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $5.47M
- P/E ratio
- –
- Price to sales
- 2.38
- Price to book
- 1.36
- Dividend yield
- –
- Free cash flow yield
- -330.30%
Fundamentals
- Revenue
- $2.30M
- Net income
- -$11.77M
- EPS, diluted
- -$4.58
- Free cash flow
- -$18.07M
- Book value per share
- $1.20
- Diluted shares
- 3M
Seven years at a glance
Fiscal years 2019 to 2025 and trailing twelve months, USD
Revenue
$2.30M+21.9% YoY
Gross profit
$1.40M+14.1% YoY
Operating income
-$17.57M
Net income
-$11.77M
EPS, diluted
-$4.58
Free cash flow
-$18.07M
Reported periodTrailing twelve months